Lung Cancer Treatment Market to exceed USD 49.4 billion by 2032, Says Graphical Research Powered by GMI
May 31, 2023 18:30 ET | Graphical Research
Selbyville, Delaware, May 31, 2023 (GLOBE NEWSWIRE) -- Lung Cancer Treatment Market size is expected to surpass USD 49.4 billion by 2032. The rising awareness regarding the treatments of chronic...
Global Allergy Immunotherapy Market
Global Allergy Immunotherapy Market Trends and Forecast Report 2023-2031
May 29, 2023 06:48 ET | Research and Markets
Dublin, May 29, 2023 (GLOBE NEWSWIRE) -- The "Global Allergy Immunotherapy Market Report and Forecast 2023-2031" report has been added to's offering.The global allergy...
Global T-Cell Immunotherapy Market
Global T-Cell Immunotherapy Market Report 2023: Increasing Prevalence of Cancer and Autoimmune Diseases Boosts Demand
May 26, 2023 09:03 ET | Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Global T-Cell Immunotherapy Market by Mechanism Of Action (Active Immunotherapy, Passive Immunotherapy), Product Class (Bispecific Antibodies,...
PDS Biotech Logo.png
PDS Biotech Announces Interim Data Demonstrates 12-Month Survival Rate of 87% with PDS0101 in Combination with KEYTRUDA® (pembrolizumab) for Head and Neck Cancer Patients
May 25, 2023 17:00 ET | PDS Biotechnology Corporation
Interim data being presented at ASCO 2023 Annual Meeting Demonstrated median progression-free survival (PFS) of 10.4 months Demonstrated 12-month overall survival (OS) rate of 87.1%A disease control...
Evaxion Logo.png
Evaxion unveils proprietary genetic adjuvant technology to boost the effect of DNA and mRNA vaccines
May 25, 2023 17:00 ET | Evaxion Biotech
Evaxion developed a genetic adjuvant technology that boosts the immune responses of viral, bacterial and cancer vaccinesPreclinically validated for both DNA and mRNA vaccines, and ready for clinical...
Atypical Teratoid Rhabdoid Tumors (ATRT) Pipeline Insights Report 2023 Featuring Novartis Pharmaceuticals, Ipsen Pharma, Chimerix, Exelixis, & Takeda Pharmaceuticals
May 23, 2023 08:58 ET | Research and Markets
Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2023" clinical trials has been added to's offering.This report...
Larkspur Biosciences.png
Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer
May 23, 2023 05:30 ET | Larkspur Biosciences, Inc.
Addressing the Key Bottlenecks in the Tumor Microenvironment That Allow a Tumor to Subvert the Immune System Financing Co-led by Polaris Innovation Fund, 3E Bioventures Capital, and Takeda...
Global Tumor Infiltrating Lymphocytes Market
Tumor Infiltrating Lymphocytes Global Market Report 2023: Sector to Reach $15.56 Billion by 2027 at a 13.7% CAGR
May 23, 2023 04:53 ET | Research and Markets
Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Tumor Infiltrating Lymphocytes Global Market Report 2023" report has been added to's offering.The global tumor infiltrating...
Valo Tx Logo.jpg
Valo Therapeutics Announces First Patient Dosed with PeptiCRAd-1 - Innovative Immuno-oncology
May 23, 2023 03:00 ET | Valo Therapeutics LTD
HELSINKI, Finland, May 23, 2023 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer, announces that the first patient has been treated in...
7 Hills Logo.png
7 Hills Pharma Surpasses $25MM Milestone in Nondilutive Funding
May 22, 2023 13:05 ET | 7 Hills Pharma
HOUSTON, May 22, 2023 (GLOBE NEWSWIRE) -- 7 Hills Pharma LLC (“7 Hills” or “7HP”) announced today that it has been awarded $13.5MM in nondilutive grant funds from the Cancer Prevention &...